Commodore Capital
New York City, New Yorkcommodorecapital.com
Overview
Commodore Capital is an investment management firm that serves as an investment advisor with discretionary trading authority to private, pooled investment vehicles. The firm may employ various long/short investment strategies, which depend on the ability to identify and purchase undervalued investments and sell short overvalued investments . The firm specializes in venture capital investments within the healthcare sector, leveraging a science-driven approach .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ollin Biosciences | Jun 2026 | Series B | Co-investor |
| Korsana Biosciences | Apr 2026 | PIPE | Co-investor |
| AN2 Therapeutics | Mar 2026 | Follow-on Offering | Co-investor |
| Lona Biotherapeutics Ltd. | Dec 2025 | Private Placement | Lead |
| Galecto Biotech | Nov 2025 | Private Placement | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
